PL412654A1 - Zastosowanie polimeru blokowego zawierającego blok poli(chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny - Google Patents

Zastosowanie polimeru blokowego zawierającego blok poli(chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny

Info

Publication number
PL412654A1
PL412654A1 PL412654A PL41265415A PL412654A1 PL 412654 A1 PL412654 A1 PL 412654A1 PL 412654 A PL412654 A PL 412654A PL 41265415 A PL41265415 A PL 41265415A PL 412654 A1 PL412654 A1 PL 412654A1
Authority
PL
Poland
Prior art keywords
block
heparin
poly
chloride
neutralization
Prior art date
Application number
PL412654A
Other languages
English (en)
Other versions
PL229768B1 (pl
Inventor
Maria Nowakowska
Krzysztof Szczubiałka
Kamil Kamiński
Andrzej Mogielnicki
Bartłomiej Kałaska
Dariusz Pawlak
Emilia Sokołowska
Original Assignee
Uniwersytet Jagielloński
Uniwersytet Medyczny W Białymstoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński, Uniwersytet Medyczny W Białymstoku filed Critical Uniwersytet Jagielloński
Priority to PL412654A priority Critical patent/PL229768B1/pl
Priority to US15/579,277 priority patent/US10052347B2/en
Priority to EP16738890.9A priority patent/EP3307281B1/en
Priority to AU2016277192A priority patent/AU2016277192A1/en
Priority to PCT/PL2016/050028 priority patent/WO2016200284A1/en
Priority to CA2987709A priority patent/CA2987709A1/en
Publication of PL412654A1 publication Critical patent/PL412654A1/pl
Publication of PL229768B1 publication Critical patent/PL229768B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24—Homopolymers or copolymers of amides or imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/02—Stable Free Radical Polymerisation [SFRP]; Nitroxide Mediated Polymerisation [NMP] for, e.g. using 2,2,6,6-tetramethylpiperidine-1-oxyl [TEMPO]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/03—Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

Przedmiotem wynalazku jest zastosowanie polimerów blokowych zawierających blok poli(chlorku 3-metakryloilaminopropylotrimetyloamoniowego) do bezpośredniej neutralizacji heparyn we krwi i płynach ustrojowych, zwłaszcza heparyny niefrakcjonowanej i heparyny drobnocząsteczkowej.
PL412654A 2015-06-10 2015-06-10 Zastosowanie polimeru blokowego zawierającego blok poli- (chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny PL229768B1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL412654A PL229768B1 (pl) 2015-06-10 2015-06-10 Zastosowanie polimeru blokowego zawierającego blok poli- (chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny
US15/579,277 US10052347B2 (en) 2015-06-10 2016-06-09 Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (PMAPTAC) for the neutralization of heparin
EP16738890.9A EP3307281B1 (en) 2015-06-10 2016-06-09 Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (pmaptac) for the neutralization of heparin
AU2016277192A AU2016277192A1 (en) 2015-06-10 2016-06-09 Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (PMAPTAC) for the neutralization of heparin
PCT/PL2016/050028 WO2016200284A1 (en) 2015-06-10 2016-06-09 Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (pmaptac) for the neutralization of heparin
CA2987709A CA2987709A1 (en) 2015-06-10 2016-06-09 Use of a block polymer comprising a block of poly(3-(methacryloylamino)propyltrimethylammonium chloride) (pmaptac) for the neutralization of heparin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL412654A PL229768B1 (pl) 2015-06-10 2015-06-10 Zastosowanie polimeru blokowego zawierającego blok poli- (chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny

Publications (2)

Publication Number Publication Date
PL412654A1 true PL412654A1 (pl) 2016-12-19
PL229768B1 PL229768B1 (pl) 2018-08-31

Family

ID=56411860

Family Applications (1)

Application Number Title Priority Date Filing Date
PL412654A PL229768B1 (pl) 2015-06-10 2015-06-10 Zastosowanie polimeru blokowego zawierającego blok poli- (chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny

Country Status (6)

Country Link
US (1) US10052347B2 (pl)
EP (1) EP3307281B1 (pl)
AU (1) AU2016277192A1 (pl)
CA (1) CA2987709A1 (pl)
PL (1) PL229768B1 (pl)
WO (1) WO2016200284A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424871A1 (pl) * 2018-03-13 2019-09-23 Uniwersytet Jagielloński Zastosowanie kopolimerów do wytwarzania preparatu do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107474160B (zh) * 2017-08-10 2019-05-28 山东师范大学 一种磷酰胆碱基聚乙二醇改性壳聚糖及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
JP2012512244A (ja) 2008-12-16 2012-05-31 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質の精製
CN102317523B (zh) 2008-12-23 2014-08-06 3M创新有限公司 官能化非织造制品
PL387249A1 (pl) 2009-02-10 2010-08-16 Uniwersytet Jagielloński Zastosowanie polimeru chitozanowego do neutralizacji heparyny
PL224855B1 (pl) 2010-04-22 2017-02-28 Univ Jagiellonski Zastosowanie modyfikowanych polisacharydów do neutralizacji heparyny
EP2842548A1 (en) 2013-08-29 2015-03-04 Universite De Liege Polymeric synthetic antidote

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424871A1 (pl) * 2018-03-13 2019-09-23 Uniwersytet Jagielloński Zastosowanie kopolimerów do wytwarzania preparatu do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1

Also Published As

Publication number Publication date
US20180161361A1 (en) 2018-06-14
WO2016200284A1 (en) 2016-12-15
US10052347B2 (en) 2018-08-21
PL229768B1 (pl) 2018-08-31
AU2016277192A1 (en) 2017-12-21
EP3307281A1 (en) 2018-04-18
CA2987709A1 (en) 2016-12-15
EP3307281B1 (en) 2019-10-16

Similar Documents

Publication Publication Date Title
CY1125144T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρηση αυτης
MX2021014739A (es) Fosfinimida de titanio y sistemas de catalizadores de iminoimidazolidida de titanio con soportes de activador.
BR112017003447A2 (pt) copolímeros de poli(oxazolina-co-etilenoimina)-epicloridrina e usos dos mesmos
PH12019501018A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EP3364891A4 (en) INTRAVASCULAR TREATMENT OF VASCULAR CLOSURE AND RELATED DEVICES, SYSTEMS AND METHOD
EP3191530A4 (en) Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
EA201890512A1 (ru) Способы лечения пациентов со злокачественными опухолями с использованием ингибиторов фарнезилтрансферазы
MY175265A (en) Primary amine-containing silicone hydrogel contact lenses and related compositions and methods
LT3962601T (lt) 5-ht2a agonistai, skirti panaudoti depresijos gydymui
EP3650476A4 (en) ELASTIC COPOLYMER CONTAINING FLUORINE, COMPOSITION OF IT AND CROSS-LINKED RUBBER ITEMS
EA033134B1 (ru) Асфальтовая композиция
MX382410B (es) Determinación de niveles de glicosaminoglicanos mediante espectrometría de masas.
BR112016029207A2 (pt) resinas de polietileno
FR3009830B1 (fr) Nouveaux complexes de polymeres hydrosolubles et leurs utilisations
FR3044663B1 (fr) Copolymere monofonctionnel ou telechelique de 1,3-butadiene et d'ethylene.
EA201891740A1 (ru) [бис(тригидрокарбилсилил)аминосилил]-функционализованный стирол и способ его получения
MX373828B (es) Composiciones poliméricas curables con humedad que tienen polímeros halogenados y mercáptidos de metal.
EP3431517A4 (en) Copolymer and surface treatment
MX346429B (es) Fluidos de tratamiento gelificables que tienen tiempos de gelificacion ajustables y metodos asociados con los mismos.
CY1122457T1 (el) Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας
MX389107B (es) Detergente en tableta para lavavajillas y metodos de fabricacion y de utilizacion del mismo.
PL412654A1 (pl) Zastosowanie polimeru blokowego zawierającego blok poli(chlorku 3-metakryloilaminopropylotrimetyloamoniowego) (PMAPTAC) do neutralizacji heparyny
FI20155194A7 (fi) Korkean taitekertoimen siloksaanimonomeerit, niiden polymerointi sekä niiden käyttö
DE112018006114A5 (de) Kanüle, kanülensystem und blutpumpensystem
EP3618888A4 (en) PERITONEAL DIALYSIS CONCENTRATE, PERITONEAL DIALYSIS BAG AND SET FOR CONTINUOUS AMBULANCE PERITONEAL DIALYSIS OR AUTOMATED PERITONEAL DIALYSIS